• Most Popular
  • Most Shared

FACTBOX: Banks see future payday from stakes in Visa

Wed Mar 19, 2008 6:51pm EDT

Stocks

   

(Reuters) - Following is a list of Visa Inc's (V.N) largest shareholders and the estimated value of their remaining equity interest in the company after each sold part of their stakes in Visa's IPO.

Stocks  |  Hot Stocks  |  IPOs  |  Funds News  |  ETFs News

Visa staged its market debut on the New York Stock Exchange on Wednesday after an IPO that raised a record $17.9 billion. The San Francisco-based credit card network saw the value of its shares close up 28.4 percent to $56.50.

Visa stockholders are subject to a lock-up period that restricts the immediate sale of their entire holdings, and the conversion of their Class B stock to Class A shares.

The estimated value of each bank's remaining stakes at Wednesday's closing price is:

* JP Morgan Chase & Co (JPM.N) -- $2.5 billion. It garnered about $1.3 billion from the sale of shares in Visa's IPO.

* Bank of America Corp (BAC.N) -- $1.2 billion. It garnered about $626 million from the sale of shares in Visa's IPO.

* National City Corp NCC.N -- $868 million. It garnered about $436 million from the sale of shares in Visa's IPO.

* Citigroup Inc (C.N) -- $598 million. It garnered about $300 million from the sale of shares in Visa's IPO.

* U.S. Bancorp (USB.N) -- $551 million. It garnered about $277 million from the sale of shares in Visa's IPO.

* Wells Fargo & Co (WFC.N) -- $544 million. It garnered about $273 million from the sale of shares in Visa's IPO.

** Source: Visa Inc amended registration statement with the U.S. Securities and Exchange Commission.

(Reporting by Lilla Zuill, Editing by Toni Reinhold)



More from Reuters

Photo

Rajaratnam pleads innocent in Galleon case

NEW YORK (Reuters) - Galleon hedge fund founder Raj Rajaratnam and co-defendant Danielle Chiesi asserted their innocence on Monday to charges of securities fraud, in what U.S. prosecutors describe as the biggest hedge fund insider trading case ever.

Demonstrators protest against the healthcare bill outside the Capitol in Washington December 15, 2009. REUTERS/Kevin Lamarque

Health bill passes crucial test

A sweeping U.S. healthcare reform bill appears headed for passage in the Senate after surviving a middle-of-the-night test vote.  Full Article | Video 

Two men shake hands in a file photo.    REUTERS/File

Let's make a deal

The battered M&A sector will make a tepid recovery in the coming year and three hot sectors will lead the way, according to a Thomson Reuters analysis.  Full Article